Gene · 4837
Papers1,489
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,489
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The biological roles and therapeutic potential of nicotinamide N-methyltransferase in ovarian cancer. | Pathol Res Pract | 2026 | 42269537 | PubTator, text mining | PubMed |
| Nicotinamide N-Methyltransferase (NNMT): A Central Regulator in Hepatocellular Carcinoma Metabolism and Therapeutic Targeting - A Systematic Review. | Curr Drug Metab | 2026 | 42260786 | PubTator, text mining | PubMed |
| LKB1 inactivation elicits an NNMT-mediated methyl sink and confers dependence on PRMT5 in lung cancer. | Cell Rep | 2026 | 42234565 | PubTator, text mining | PubMed |
| Nicotinamide N-methyltransferase in inflammatory bowel disease: Multidimensional regulation, mechanistic insights, and therapeutic potential. | Exp Cell Res | 2026 | 42229816 | PubTator, text mining | PubMed |
| Identification of shared diagnostic biomarkers and molecular pathways between chronic kidney disease and renal cell carcinoma using transcriptomics and machine learning. | Transl Cancer Res | 2026 | 42180890 | PubTator, text mining | PubMed |
| Multi-Omics profiling identify NNMT in tumor endothelium as a key regulator of CD8⁺ T cell exhaustion via the TGF signaling pathway. | Transl Oncol | 2026 | 42140035 | PubTator, text mining | PubMed |
| Emerging opportunities for nicotinamide N-methyltransferase (NNMT) inhibitor clinical translation. | Trends Pharmacol Sci | 2026 | 42067476 | PubTator, text mining | PubMed |
| Exploring the common ferroptosis-related genes and molecular mechanisms in periodontitis and systemic sclerosis via integrated bioinformatics and experimental analysis. | Front Cell Dev Biol | 2026 | 42004467 | PubTator, text mining | PubMed |
| Nicotinamide N-methyltransferase as a therapeutic target in taxane-resistant castration-resistant prostate cancer. | Cell Death Discov | 2026 | 41997904 | PubTator, text mining | PubMed |
| Structure-Based Drug Discovery of Non-SAM-Mimetic Bisubstrate Inhibitors against Nicotinamide N‑Methyltransferase. | ACS Med Chem Lett | 2026 | 41982718 | PubTator, text mining | PubMed |
| Cancer-Associated Fibroblasts Promote Tumor Immunosuppression in Hepatocellular Carcinoma via the NNMT-ANGPTL4 Axis. | Adv Sci (Weinh) | 2026 | 41980209 | PubTator, text mining | PubMed |
| Genetic Markers of Tumor Multiplicity in Non-melanoma Skin Cancer: Associations of 19 SNPs in an Italian Cohort. | Dermatol Ther (Heidelb) | 2026 | 41964798 | PubTator, text mining | PubMed |
| NNMT as a therapeutic target in fibrosis: Insights from the heart, liver, kidneys, and lungs. | Differentiation | 2026 | 41950636 | PubTator, text mining | PubMed |
| Stromal NNMT overexpression as an independent prognostic biomarker in lung adenocarcinoma and breast carcinoma. | Carcinogenesis | 2026 | 41913584 | PubTator, text mining | PubMed |
| Efficacious Anti-Cancer Drugs Targeting Nicotinamide N-Methyltransferase (NNMT) in Cultured Human Oral Squamous Cell Carcinoma (OSCC). | Pharmaceuticals (Basel) | 2026 | 41901361 | PubTator, text mining | PubMed |
| Colony-stimulating factor-2 triggers NNMT-dependent myofibroblast activation in head and neck cancer. | Oncogene | 2026 | 41896590 | PubTator, text mining | PubMed |
| p16High immune cells control disease tolerance as a defense and health span-extending strategy. | Immunity | 2026 | 41895292 | PubTator, text mining | PubMed |
| Detachment-Induced FAK-STAT3-NNMT Inhibits CTCs Anoikis to Promote Breast Cancer Metastasis by Enhancing Fatty Acid Oxidation. | Adv Sci (Weinh) | 2026 | 41816955 | PubTator, text mining | PubMed |
| Pretreatment KRAS-Mutant Circulating Tumor DNA Predicts Incidence and Patterns of Recurrence in Patients Undergoing Radiofrequency Ablation for Colorectal Liver Metastases: A Prospective Analysis. | JCO Precis Oncol | 2026 | 41802190 | PubTator, text mining | PubMed |
| Epigenomic and Metabolic Interplay in the Development of Metastatic Brain Tumors. | Oncol Res | 2026 | 41799524 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4837/papers?page=2